Publications by authors named "Per Sangfelt"

Claim this Profile
P
Placement of a transjugular intrahepatic portosystemic shunt in addition to recanalization of acute and chronic portomesenteric vein occlusions - a retrospective evaluation.
Charlotte Ebeling Barbier, Fredrik Rorsman, Lars-Gunnar Eriksson, Per Sangfelt, Reza Sheikhi

Acta Radiol Open· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mycophenolate mofetil treatment in patients with autoimmune hepatitis failing standard therapy with prednisolone and azathioprine.
Georgios Giannakopoulos, Hans Verbaan, Inga-Lill Friis-Liby, Per Sangfelt, Nils Nyhlin

Dig Liver Dis· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of acute portomesenteric venous thrombosis with thrombectomy through a transjugular intrahepatic portosystemic shunt: a single-center experience.
Kerstin Rosenqvist, Charlotte Ebeling Barbier, Fredrik Rorsman, Per Sangfelt, Rickard Nyman

Acta Radiol· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Active cytomegalovirus infection diagnosed by real-time PCR in patients with inflammatory bowel disease: a prospective, controlled observational study (.).
Mari Thörn, Fredrik Rorsman, Anders Rönnblom, Per Sangfelt, Alkwin Wanders

Scand J Gastroenterol· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endovascular treatment of symptomatic Budd-Chiari syndrome - in favour of early transjugular intrahepatic portosystemic shunt.
Kerstin Rosenqvist, Reza Sheikhi, Lars-Gunnar Eriksson, Rupesh Rajani, Fredrik Rorsman, Per Sangfelt

Eur J Gastroenterol Hepatol· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endovascular treatment of acute and chronic portal vein thrombosis in patients with cirrhotic and non-cirrhotic liver.
Kerstin Rosenqvist, Lars-Gunnar Eriksson, Fredrik Rorsman, Per Sangfelt, Rickard Nyman

Acta Radiol· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Acute renal failure is a common complication in liver cirrhosis].
Hans Verbaan, Per Sangfelt

Lakartidningen· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatocellular and extrahepatic cancer in patients with autoimmune hepatitis--a long-term follow-up study in 634 Swedish patients.
Åsa Danielsson Borssén, Sven Almer, Hanne Prytz, Sven Wallerstedt, Inga-Lill Friis-Liby, Per Sangfelt

Scand J Gastroenterol· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monitoring dominant strictures in primary sclerosing cholangitis with brush cytology and FDG-PET.
Per Sangfelt, Anders Sundin, Alkwin Wanders, Ib Rasmussen, Britt-Marie Karlson

J Hepatol· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vanishing bile duct-like syndrome in a patient with Hodgkin lymphoma - pathological development and restitution.
Karin Hallén, Per Sangfelt, Thomas Nilsson, Hans Nordgren, Alkwin Wanders

Acta Oncol· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased fecal levels of chromogranin A, chromogranin B, and secretoneurin in collagenous colitis.
Michael Wagner, Mats Stridsberg, Christer G B Peterson, Per Sangfelt, Maria Lampinen

Inflammation· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eosinophil associated genes in the inflammatory bowel disease 4 region: correlation to inflammatory bowel disease revealed.
Kristin Blom, Jenny Rubin, Jonas Halfvarson, Leif Törkvist, Anders Rönnblom, Per Sangfelt

World J Gastroenterol· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fecal eosinophil cationic protein as a marker of active disease and treatment outcome in collagenous colitis: a pilot study.
Michael Wagner, Christer G B Peterson, Ingrid Stolt, Per Sangfelt, Margret Agnarsdottir

Scand J Gastroenterol· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Budesonide treatment of patients with collagenous colitis restores normal eosinophil and T-cell activity in the colon.
Michael Wagner, Maria Lampinen, Per Sangfelt, Margret Agnarsdottir, Marie Carlson

Inflamm Bowel Dis· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics and long-term outcome of patients with autoimmune hepatitis related to the initial treatment response.
Mårten Werner, Sven Wallerstedt, Stefan Lindgren, Sven Almer, Einar Björnsson, Per Sangfelt

Scand J Gastroenterol· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of hepatitis C virus infection: updated Swedish Consensus recommendations.
Martin Lagging, Rune Wejstål, Ingrid Uhnoo, Barbro Gerdén, Björn Fischler, Per Sangfelt

Scand J Infect Dis· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiology and the initial presentation of autoimmune hepatitis in Sweden: a nationwide study.
Mårten Werner, Hanne Prytz, Bodil Ohlsson, Sven Almer, Einar Björnsson, Per Sangfelt

Scand J Gastroenterol· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Budd-Chiari syndrome in Sweden: epidemiology, clinical characteristics and survival - an 18-year experience.
Rupesh Rajani, Tor Melin, Einar Björnsson, Ulrika Broomé, Per Sangfelt

Liver Int· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatic and extrahepatic malignancies in autoimmune hepatitis. A long-term follow-up in 473 Swedish patients.
Mårten Werner, Sven Almer, Hanne Prytz, Stefan Lindgren, Sven Wallerstedt, Per Sangfelt

J Hepatol· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Different regulation of eosinophil activity in Crohn's disease compared with ulcerative colitis.
Maria Lampinen, Marie Backman, Ola Winqvist, Fredrik Rorsman, Anders Rönnblom, Per Sangfelt

J Leukoc Biol· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accumulation, activation, and survival of neutrophils in ulcerative colitis: regulation by locally produced factors in the colon and impact of steroid treatment.
Maria Lampinen, Per Sangfelt, Yesuf Taha, Marie Carlson

Int J Colorectal Dis· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fecal markers of inflammation used as surrogate markers for treatment outcome in relapsing inflammatory bowel disease.
Michael Wagner, Christer G B Peterson, Peter Ridefelt, Per Sangfelt, Marie Carlson

World J Gastroenterol· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A low-dose intradermal hepatitis B vaccine programme in health-care workers and students is highly effective and cost saving: a retrospective follow-up survey in the clinical setting.
Per Sangfelt, Ingrid Uhnoo, Olle Reichard, Ola Weiland

Scand J Gastroenterol· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The proinflammatory CXC-chemokines GRO-alpha/CXCL1 and MIG/CXCL9 are concomitantly expressed in ulcerative colitis and decrease during treatment with topical corticosteroids.
Arne Egesten, Mette Eliasson, Anders I Olin, Jonas S Erjefält, Anders Bjartell, Per Sangfelt

Int J Colorectal Dis· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FBXW7/hCDC4 is a general tumor suppressor in human cancer.
Shahab Akhoondi, Dahui Sun, Natalie von der Lehr, Sophia Apostolidou, Kathleen Klotz, Per Sangfelt, Olle Sangfelt

Cancer Res· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis